Perioperative Impella 5.5 Support for Surgical Aortic Valve Replacement: Pull Back/Push Through Technique, Safeguards, and Pitfalls.
Dina Al RameniMehmet AkayIsmael Salas de ArmasManish K PatelJayeshkumar PatelJuan MarcanoCristian Sorin SarateanuBiswajit KarIgor D GregoricPublished in: ASAIO journal (American Society for Artificial Internal Organs : 1992) (2022)
In patients undergoing aortic valve surgery, preoperative reduced left ventricular ejection fraction is not uncommon and is associated with poor outcomes. Mechanical circulatory support (MCS) may be preemptively used in patients presenting with high periprocedural risk. The Impella 5.5 is a percutaneous left ventricular assist device that has been increasingly used in various cardiac surgeries. In this article, we present a step-by-step guide, safeguards, and pitfalls on how to replace the aortic valve and preserve this transaortic MCS device for postoperative support in patients with concomitant aortic valve pathology and left ventricular dysfunction.
Keyphrases
- aortic valve
- aortic stenosis
- aortic valve replacement
- patients undergoing
- left ventricular assist device
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- left ventricular
- ejection fraction
- minimally invasive
- extracorporeal membrane oxygenation
- heart failure
- acute myocardial infarction
- type diabetes
- coronary artery disease
- coronary artery bypass
- percutaneous coronary intervention
- cardiac resynchronization therapy
- direct oral anticoagulants
- hypertrophic cardiomyopathy
- metabolic syndrome
- venous thromboembolism
- atrial fibrillation
- left atrial